Japan­ese CMO Fu­ji­film Diosynth spends ex­tra $28M in US, UK mAb fa­cil­i­ties

Fu­ji­film Diosynth Biotech­nolo­gies is chan­nel­ing an­oth­er $28 mil­lion from its par­ents com­pa­ny in­to two new man­u­fac­tur­ing fa­cil­i­ties in Texas and the UK, ag­gres­sive­ly adding equip­ment and space to $123 mil­lion worth of ma­chines and build­ings that were just an­nounced in April.

A rel­a­tive new­com­er to the con­tract de­vel­op­ment and man­u­fac­tur­ing busi­ness, the sub­sidiary of Japan­ese Fu­ji­film Corp is keen on gain­ing mar­ket share from the likes of Lon­za and Catal­ent. The two sites be­ing ex­pand­ed spe­cial­ize in mon­o­clon­al an­ti­bod­ies; due to high de­mand, the com­pa­ny says they de­cid­ed to pour in ex­tra mon­ey ear­li­er than sched­uled, even be­fore the fa­cil­i­ties are ful­ly op­er­a­tional.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.